Last updated: December 2025. (Information below is for general education and market analysis—not legal advice.)
Morocco has moved from being synonymous with informal cannabis cultivation to becoming one of the most closely watched regulated medical/industrial cannabis markets globally. The shift is anchored in Law 13-21, which allows cannabis activities for medical, pharmaceutical, and industrial purposes under a state licensing framework administered by ANRAC (the National Agency for the Regulation of Cannabis-Related Activities). (Cabinet Me de Nyary Comandini)
What makes Morocco uniquely “global” is the intent: formalise a historic cultivation region (the Rif), protect farmers from illicit networks, and compete in international supply chains—where compliance, not tradition, sets the price.
1) The legal foundation: what Law 13-21 actually authorises
At the heart of Morocco’s model is a simple rule: no cannabis-related activity without authorisation.
Activities that require ANRAC authorisation (the “licensed chain”)
Law 13-21 lists regulated activities that require an ANRAC authorisation, including: cultivation/production, nurseries, seed import/export, processing/manufacturing, transport, marketing, and export/import of cannabis products. (Cabinet Me de Nyary Comandini)
| Supply-chain activity | Licensed? | Typical players |
| Cultivation & production | ✅ | Local farmers (via cooperatives) |
| Nurseries | ✅ | Licensed entities producing young plants |
| Seed import/export | ✅ | Licensed operators |
| Processing/manufacturing | ✅ | Industrial & pharmaceutical processors |
| Transport & storage | ✅ | Licensed logistics with security/traceability |
| Marketing & export | ✅ | Licensed Moroccan companies/legal entities |
Key point: Morocco is building a “closed loop” compliance chain designed for traceability, contracting, and controlled distribution. (Cabinet Me de Nyary Comandini)
2) Where cultivation is permitted (and why it matters)
Law 13-21 restricts cultivation to provinces defined by decree, and Morocco initially focused on three historic producing provinces in the Rif: Al Hoceima, Chefchaouen, and Taounate. (Cabinet Me de Nyary Comandini)
Why this matters for business:
If your land, cooperative, or upstream supply sits outside the designated zones, you don’t have a scalable compliance story—no matter how strong the agronomy is.
3) Who can grow? Morocco’s cooperative-first model
Morocco’s approach is explicitly farmer-centric, but with strict eligibility criteria. To obtain a cultivation/production authorisation, the applicant must (among other conditions) be Moroccan, of legal age, reside locally, and join a cannabis-specific cooperative. Growers must use certified seeds/young plants and deliver the harvest through the cooperative framework. (Cabinet Me de Nyary Comandini)
Strategic implication: this design is meant to:
- pull farmers out of grey-market dependency,
- standardise production through specs and contracts,
- and reduce exposure to trafficking networks.
Morocco reinforced that transition with royal pardons for thousands convicted/wanted for cannabis-farming offences—explicitly framed as encouraging integration into the legal sector. (Reuters)
4) THC limits: the compliance line between “industrial” and “medical”
Morocco’s framework differentiates by purpose. In practice, a widely referenced regulatory benchmark is a 1% THC threshold for non-medical/pharma uses, while higher-THC pathways are reserved for medical/pharmaceutical channels (subject to additional controls). (anrac.gov.ma)
On the finished product side, Morocco has also signalled tighter THC tolerances for specific consumer categories—for example, reporting that dietary supplements must remain below 0.3% THC and cosmetics below 0% THC (as described in Moroccan business reporting tied to the rollout of legal products). (Morocco World News)
Takeaway: Morocco is balancing export market expectations (quality and safety) with domestic political realities (strict control over exposure to psychoactive substances).
5) Licensing reality check: the market scaled fast
Morocco’s regulator reported a sharp expansion in licensing and production:
- 2023: first legal harvest reported at 294 metric tons, with cooperatives and farmers operating on a limited footprint. (Reuters)
- 2024: ANRAC reported 3,371 licenses granted (including 3,056 tied to cultivation/production and 315 for operators across processing, marketing, export, transport, seed import, and nurseries), alongside legal production of 4,082.4 tons. (Morocco World News)
This is what “regulatory scale-up” entails: not just permits for farms, but also permits for the midstream (processing/logistics) that make exports feasible.
6) Products: from raw material to “authorised” cannabis-based goods
Morocco’s product pathway is split:
A) Medical & pharmaceutical products
Cannabis-based medicines sit under Morocco’s broader medicines framework (alongside cannabis-specific rules), creating a more “pharma-like” approval logic (quality, safety, authorisation, and controlled distribution). (Cabinet Me de Nyary Comandini)
B) Industrial/cosmetic/supplement products
In 2025, Morocco reported 67 cannabis-derived products authorised for marketing, including 26 cosmetics and 41 dietary supplements, registered through the country’s medicines/health-products regulator (AMMPS). (Newsweed)
Why this matters commercially: approvals expand Morocco’s exportable SKU set beyond biomass/resin into higher-margin finished goods—but they also raise compliance cost (testing, documentation, labelling, stability, etc.).
7) Exports: Morocco’s “beyond” story (and the compliance trap)
Exports are where Morocco’s policy meets global reality.
- Morocco publicly entered the legal export market, including a widely reported shipment of low-THC resin to Switzerland as part of early international market entry. (Le Monde.fr)
- By late 2025, business reporting described Morocco’s first international sale of a cannabis-based medicine (via a Moroccan firm and a South African pharma partner). (Ecofin Agency)
The compliance trap (common investor mistake)
Export success is rarely determined by cultivation costs alone. Importing countries typically require:
- pharmaceutical-grade GxP alignment (often GMP expectations for medical supply),
- validated batch testing and stability/contaminant controls,
- narcotics permits and controlled chain-of-custody,
- and documentation tight enough to withstand audits.
Morocco is building toward that—but it’s still a maturation journey.
Pros and Cons of Morocco’s Medical Cannabis Model
Pros
1) Clear legal framework + single regulator
A defined law and a dedicated regulator reduce ambiguity for operators and counterparties. (Cabinet Me de Nyary Comandini)
2) Farmer integration (social stability + legitimacy)
Cooperative-based licensing can increase rural income stability and reduce trafficking dependence—especially when combined with state incentives like pardons. (Reuters)
3) Rapid licensing scale and production ramp
The jump from a first harvest in 2023 to thousands of licenses and multi-thousand-ton production in 2024 signals serious state capacity-building. (Reuters)
4) Growing product pipeline
Authorising dozens of cannabis-derived products (cosmetics/supplements now; medicines next) supports higher-value industrialisation. (Newsweed)
Cons
1) Geography restrictions limit expansion
Cultivation tied to specific provinces protects oversight but can constrain scaling and exclude capable growers outside the zones. (Cabinet Me de Nyary Comandini)
2) Bureaucracy and compliance cost
Licensing, specs, certified inputs, contracts, storage security, testing, and audits can overwhelm small operators.
3) Competition with the illicit market
Legal channels must be price-competitive and reliable—or farmers may keep one foot in informal trade (a known risk in transitions like this).
4) Climate + agronomy risk
Rif agriculture is exposed to heat/water stress; sustainability and varietal choices will materially impact yields and costs.
What to watch next (2026 signals)
Two indicators matter most for Morocco’s next phase:
- Cultivated area and seed authorisation trends — reporting in 2025 pointed to expanded legal acreage and increased authorisation of local seed quantities, consistent with formal market growth. (Newsweed)
- Pharma-grade export repeatability — the real milestone isn’t “a first shipment,” but repeat shipments with consistent quality, documentation, and buyer confidence.
Q&A: Medical Cannabis in Morocco (Fast, Practical Answers)
Q1) Is medical cannabis legal in Morocco?
Yes—for medical, pharmaceutical, and industrial purposes under Law 13-21, through an authorisation system overseen by ANRAC. Recreational use remains illegal. (Cabinet Me de Nyary Comandini)
Q2) Can anyone cultivate cannabis legally?
No. Cultivation authorisation is restricted and requires eligibility conditions (including Moroccan nationality, local residency, and cooperative participation for growers). (Cabinet Me de Nyary Comandini)
Q3) Where can legal cultivation happen?
Only in provinces designated by decree—initially including Al Hoceima, Chefchaouen, and Taounate. (Cabinet Me de Nyary Comandini)
Q4) What parts of the supply chain need licenses?
Essentially the entire chain: cultivation, nurseries, seed import/export, processing, transport, marketing, and export/import of products. (Cabinet Me de Nyary Comandini)
Q5) What THC level is allowed?
A commonly cited benchmark is 1% THC for industrial pathways, with higher THC reserved for medical/pharma channels under stricter controls. (anrac.gov.ma)
Q6) Are cannabis cosmetics and supplements allowed?
Yes. Morocco reported 67 authorised cannabis-derived products (26 cosmetics, 41 supplements) registered through AMMPS in 2025. (Newsweed)
Q7) Can Morocco export medical cannabis?
Yes. Morocco has reported legal exports (including early low-THC resin shipments) and later reported the international movement of medical cannabis products. (Le Monde.fr)
Q8) How long do ANRAC authorisations last?
Legal analyses and industry guides commonly describe authorisations as multi-year and renewable (often cited as 10-year renewable, depending on the authorisation type and compliance requirements). (CMS Law)
Q9) Can foreign companies get Moroccan licenses directly?
Typically, authorisations are structured around Moroccan legal entities and Morocco-specific eligibility requirements. Foreign participation is typically structured through partnerships, JVs, or Moroccan-incorporated entities rather than “fly-in licensing.”
Q10) What’s the most significant operational risk for new entrants?
Underestimating compliance: traceability, quality systems, documentation, and export readiness can cost more (and take longer) than cultivation itself.